Role of fungal antigens in eosinophilia-associated cellular responses in nasal polyps: A comparison with enterotoxin

Clinical and Experimental Allergy

Volumn 41, Issue 2, 2011, Pages 171-178

  Okano, M ^a   Fujiwara, T ^a   Haruna, T ^a   Kariya, S ^a   Makihara, S ^a   Higaki, T ^a   Nishizaki, K ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cytokine; Enterotoxin; Eosinophil; Fungi; Nasal polyps

Indexed keywords

BETA GLUCAN; CHITIN; FUNGAL EXTRACT; FUNGUS ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; MANNAN; RANTES; STAPHYLOCOCCUS ENTEROTOXIN; UBIQUITIN;

ADULT; AGED; AIRBORNE FUNGUS; ALTERNARIA; ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; CELL STRAIN; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DISPERSED NASAL POLYP CELL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; NOSE POLYP; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTIGENS, FUNGAL; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; EOSINOPHILIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; YOUNG ADULT;

EID: 78651453822     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03584.x     Document Type: Article

References (35)

1. Borish L. Sinusitis and asthma: entering the realm of evidence-based medicine. J Allergy Clin Immunol 2002; 109:606-8.
2. Bachart C, Zhang N, van Zele T, Gevaert P, Patou J, van Cauwenberge P. Staphylococcus aureus enterotoxins as immune stimulants. In: Halilos DL, Baroody FM, eds. Chronic rhinosinusitis. Pathogenesis and medical management. New York: Informa Healthcare USA Inc., 2007; 163-75.
3. Ponikau JU, Sherris DA, Kita H. The role of ubiquitous airborne fungi in chronic rhinosinusitis. In: Halilos DL, Baroody FM, eds. Chronic rhinosinusitis. Pathogenesis and medical management. New York: Informa Healthcare USA Inc., 2007; 177-84.
4. Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003; 17:321-6.
5. Conley DB, Tripathi A, Seiberling KA et al. Superantigens and chronic rhinosinusitis: skewing of T cell receptor V beta-distributions in polyp-derived CD4+and CD8+ T cells. Am J Rhinol 2006; 20:534-9.
6. Van Zele T, Gevaert P, Watelet JB et al. Staphylococcus aureus colonization and IgE antibody formation on enterotoxin is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114:981-3.
7. Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005; 115:1189-96.
8. 2 suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly via an EP2-mediated pathway in nasal polyps. J Allergy Clin Immunol 2009; 123:868-74.
9. Douglas R, Bruhn M, Tan LW, Ooi R, Psaltis A, Wormald PJ. Response of peripheral blood lymphocytes to fungal extracts and staphylococcal superantigen B in chronic rhinosinusitis. Laryngoscope 2007; 117:411-4.
10. Okano M, Hattori H, Yoshino T et al. Nasal exposure to Staphylococcal enterotoxin enhances the development of allergic rhinitis in mice. Clin Exp Allergy 2005; 35:506-14.
11. Ponikau JU, Sherris DA, Kern EB et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-84.
12. Braun H, Buzina W, Freudenshuss K, Beham A, Stammberger H. Eosinophilic fungal rhinosinusiti: a common disorder in Europe? Laryngologoscope 2003; 113:264-9.
13. Yamashita Y, Okano M, Yoshino T et al. Carbohydrate expressed on Aspergillus fumigatus induce in vivo allergic Th2-type response. Clin Exp Allergy 2002; 32:776-82.
14. Kobayashi T, Iijima K, Radhakrishan S et al. Asthma-related environmental fungus, alternaria, activates dendritic cells and produces potent Th2 adjuvnat activity. J Immunol 2009; 182:2502-10.
15. Inoue Y, Matsuzaki Y, Shin S-H et al. Non-pathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175:5439-47.
16. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, bouble-blind clinical trial. J Allergy Clin Immunol 2004; 113:1122-8.
17. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind trial. J Allergy Clin Immunol 2005; 115:125-31.
18. Ebbens FA, Scadding GK, Badia L et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118:1149-56.
19. Ebbens FA, Georgals C, Luiten S et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a munticenter randomized controlled study. Laryngoscope 2009; 119:401-8.
20. Shin S-H, Ponikau JU, Sherris DA et al. Rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114:1369-75.
21. Inoue K, Takano H, Oda T et al. Candida soluble cell wall beta-D-glucan induces lung inflammation in mice. Int J Immunopathol Pharmacol 2007; 20:499-508.
22. Benninger MS, Ferguson BJ, Hadley JA et al. Adult chronic rhinosinusitis: defenitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003; 129:S1-32.
23. Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology 1993; 107:183-4.
24. Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007; 119:1303-10.
25. Hamilos DL, Leung DYM, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998; 28:1145-52.
26. Yamamoto H, Okamoto Y, Horiguchi S, Kunii N, Yonekura S, Nakayama T. Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy 2007; 62:1451-5.
27. Meyer JE, Bartels J, Gorogh T et al. The role RANTES in nasal polyposis. Am J Rhinol 2005; 19:15-20.
28. Rementeria A, Lopez-Molina N, Ludwig A et al. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 2005; 22:1-23.
29. Reddy LV, Kumar A, Kurup VP. Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Mol Cell Probes 1993; 7:121-6.
30. Papon JF, Coste A, Gendron MC et al. HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope 2002; 112:2067-75.
31. Lamphear JG, Stevens KR, Rich RR. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. J Immunol 1998; 160:615-23.
32. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 1998; 110:1485-96.
33. Hearn VM, Sietsma JH. Chemical and immunological analysis of the Aspergillus fumigatus cell wall. Microbiology 1994; 140:789-95.
34. Hansen MY, Wold K, Smestad Paulsen B, Cohen EH, Karlsson-Borga A. Allergens in Aspergillus fumigatus. I. Characterization of two different allergen extracts and evaluation of their stability and the importance of carbohydrate for IgE binging. Allergy 1994; 49:235-41.
35. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, Ross GD. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 1999; 162:2281-90.